Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 0 |
| Since 2016 (last 10 years) | 0 |
| Since 2006 (last 20 years) | 1 |
Descriptor
| At Risk Persons | 1 |
| Compliance (Psychology) | 1 |
| Diagnostic Tests | 1 |
| Diseases | 1 |
| Drug Therapy | 1 |
| Foreign Countries | 1 |
| Health Behavior | 1 |
| Hypertension | 1 |
| Intelligence Quotient | 1 |
| Measures (Individuals) | 1 |
| Outcomes of Treatment | 1 |
| More ▼ | |
Source
| Intelligence | 1 |
Author
| Batty, G. David | 1 |
| Deary, Ian J. | 1 |
| Fowkes, F. Gerald R. | 1 |
| Gale, Catharine R. | 1 |
| Murray, Gordon D. | 1 |
| Price, Jacqueline F. | 1 |
| Stewart, Marlene C. W. | 1 |
Publication Type
| Journal Articles | 1 |
| Reports - Research | 1 |
Education Level
Audience
Location
| United Kingdom (Scotland) | 1 |
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Intelligence and Persisting with Medication for Two Years: Analysis in a Randomised Controlled Trial
Peer reviewed
Direct linkDeary, Ian J.; Gale, Catharine R.; Stewart, Marlene C. W.; Fowkes, F. Gerald R.; Murray, Gordon D.; Batty, G. David; Price, Jacqueline F. – Intelligence, 2009
The study examined whether verbal intelligence is associated with persisting to take medication for up to two years. The design is a prospective follow-up of compliance with taking medication in high-risk individuals participating in a randomised, placebo-controlled trial set in Central Scotland. Participants were 1993 people aged between 50 and…
Descriptors: Outcomes of Treatment, Measures (Individuals), Intelligence Quotient, Foreign Countries
